Regulatory and Human Study Operations (RHSO) Core C
Regulatory and Human Study Operations (RHSO) Core C
批准号:
10689308
负责人:
ROBERTA EILEEN BRINTON
金额:
$27.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-30 至 2026-08-31
关键词:
AddressAdherenceAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmericanCognitiveConsent FormsDataData CollectionData Science CoreDevelopmentDocumentationEnsureEthicsFinancial DisclosuresGoalsGood Clinical PracticeGood Manufacturing ProcessGuidelinesHealthHealth Insurance Portability and Accountability ActHumanHuman ResourcesIndependent LivingInstitutional Review BoardsInternationalLongevityMissionMonitorParticipantProceduresProcessProductivityProtocol ComplianceProtocols documentationQuality ControlRegulationReproducibilityResearchRiskSafetyServicesSiteSpecimenSystemTrainingTraining ProgramsTranslational ResearchUpdateWorkdata acquisitiondata qualitydata sharingethnic diversityexperienceexperimental studygood laboratory practicehealthspanhuman studyhuman subjectimprovedmaterial transfer agreementoperationpreventprogramsreal time monitoringsample collectionsexsocioeconomicssymposiumvirtual
中文摘要
总结/摘要:监管和人体研究操作核心C
监管和人类研究运营(RHSO)核心支持精密老化网络的
(PAN)通过确保人体实验的科学严谨性和法规合规性,
在项目1、2、3和4中进行。RHSO核心监督标准操作的实施
程序(SOP)、稽查和对人类研究人员进行监管和质量控制培训
流程.该核心还将有助于解决标本真实的实时监测的潜在问题,
数据采集
RHSO核心目标和目的包括执行和管理所有人的监管流程。
根据需要的核心和项目。RHSO核心将与数据科学(DS)核心合作,以确保道德,
精确和可再现的人体研究数据收集和质量,并将制定和执行遵守
人体研究数据和样本采集的SOP。RHSO核心还将支持和启用数据
分享,以加快研究成果的转化,优化认知健康,防止或减少
阿尔茨海默病(AD)和AD相关性痴呆(ADRD)的负担。
RHSO核心由Brinton领导,他是国际公认的发现和翻译
神经科学家,拥有领导高效团队进行大规模
里程碑驱动的项目。她建立了一个强大的团队来协助这项工作。其中包括埃尔南德斯
具有根据既定SOP、药物临床试验质量管理规范(GCP)执行大型项目的经验,
和国际协调会议(ICH)指南,以满足所有联邦和地方法规,以及
Rodgers在执行药物非临床研究质量管理规范(GLP)和药物非临床研究质量管理规范(GLP)方面拥有丰富的经验,
生产规范(GMP)。
英文摘要
SUMMARY/ABSTRACT: Regulatory and Human Study Operations Core C
The Regulatory and Human Study Operations (RHSO) Core supports the Precision Aging Network’s
(PAN) goals and objectives by ensuring scientific rigor and regulatory compliance of human experiments
conducted in Projects 1, 2, 3 and 4. The RHSO Core oversees implementation of standard operating
procedures (SOPs), auditing, and training of human study personnel in regulatory and quality control
processes. This Core also will contribute to solving potential issues with real time monitoring of specimen and
data acquisition.
The RHSO Core goals and objectives include execution and management of regulatory processes for all
Cores and Projects as required. The RHSO Core will work with the Data Science (DS) Core to ensure ethical,
precise and reproducible human study data collection and quality, and will develop and enforce adherence to
the SOPs for human study data and sample collection. The RHSO Core will also support and enable data
sharing to expedite translation of research to optimize cognitive healthspan and to prevent or reduce the
burden of Alzheimer’s disease (AD) and AD-related dementias (ADRD).
The RHSO Core is led by Brinton who is an internationally recognized discovery and translational
neuroscientist with a well-established track record of leading highly effective teams conducting large scale
milestone-driven projects. She has established a strong team to assist in this effort. This includes Hernandez
with experience in executing large projects in accordance to established SOP, good clinical practices (GCPs),
and International Conference on Harmonization (ICH) guidelines to fulfill all federal and local regulations, and
Rodgers who has extensive experience executing in Good Laboratory Practices (GLPs) and Good
Manufacturing Practices (GMPs).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Research in Alzheimer's Disease and related Dementias (TRADD)
-
批准号:10709167
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
-
批准号:10698555
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10560591
-
项目类别:
-
资助金额:$154.45万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10344556
-
项目类别:
-
资助金额:$212.12万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10547639
-
项目类别:
-
资助金额:$133.74万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10707107
-
项目类别:
-
资助金额:$119.93万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Research Education Component
-
批准号:10264194
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10491851
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10270190
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10199069
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:9991710
-
项目类别:
-
资助金额:$737.08万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel formulations of Allopregnanolone to treat Alzheimer's Disease
-
批准号:9906039
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10411886
-
项目类别:
-
资助金额:$755.24万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10674824
-
项目类别:
-
资助金额:$728.0万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:9793963
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10437663
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10645075
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal Endophenotype
-
批准号:9770740
-
项目类别:
-
资助金额:$114.13万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10475657
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10219144
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
海外基金